Shorla Oncology’s IMKELDI approved by FDA for leukaemia cancers
The Food and Drug Administration (FDA) has approved Shorla Oncology‘s IMKELDI for the treatment of specific leukaemia cancer forms.
The Food and Drug Administration (FDA) has approved Shorla Oncology‘s IMKELDI for the treatment of specific leukaemia cancer forms.
What's Your Reaction?
